Data Bytes: Venture megarounds tracking to new record

Goldfinch Bio Inc. has raised the forty-seventh megaround of the year, putting the biotech sector on pace to close 92 venture financings of $100 million or more. That would be a 61% increase compared with 2019, itself a record-setting year that had 57 deals of $100 million or more, and more than 3x the number of $100 million-plus deals in 2017.

Goldfinch, which is developing therapies to treat kidney diseases, raised $100 million in a series B round led by Eventide Asset Management (see “Eventide Leads $100M B round”). ...